Olean man sentenced to 3-9 years for hit-and-run death
Breaking News
KELLEN M. QUIGLEY kquigley@oleantimesherald.com 
August 27, 2025
OLEAN — An Olean man has been sentenced to three to nine years in state prison for a 2023 hit-and-run incident on Seneca Avenue that resulted in a wom...
Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology
Press Releases
Novo Nordisk Inc.  
March 29, 2025

Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology

SOUL study showed Rybelsus® (semaglutide) tablets 14 mg reduced the risk of major adverse cardiovascular events (MACE) by 14% (ARR 2% absolute risk reduction at 3 years) vs placebo in

avatar profile Olean Times Herald

Olean Times Herald


Local & Social